Evidence map›Paper›PMID 30321096›Full record

ArticleJournal of global oncology2018

International Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical Outcomes.

Maud Hanappe, Lowell T Nicholson, Shekinah N C Elmore, Alexandra E Fehr, Jean Bosco Bigirimana, Ryan C Borg, John Butonzi, Cyprien Shyirambere, Egide Mpanumusingo, Marie O Benewe and 5 more

Abstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Maud HanappeMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Lowell T NicholsonMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Shekinah N C ElmoreMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Alexandra E FehrMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Jean Bosco BigirimanaMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Ryan C BorgMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
John ButonziMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Cyprien ShyirambereMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Egide MpanumusingoMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Marie O BeneweMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Dan M KanyikeMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Scott TriedmanMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Lawrence N ShulmanMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Christian RusangwaMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.
Paul H ParkMaud Hanappe, Free University of Brussels, Brussels, Belgium; Lowell T. Nicholson, Duke University School of Medicine, Durham, NC; Shekinah N.C. Elmore, Harvard Radiation Oncology Program; Shekinah N.C. Elmore and Paul H. Park, Harvard Medical School; Ryan C. Borg, Boston College School of Social Work; Paul H. Park, Brigham and Women's Hospital; Paul H. Park, Partners in Health, Boston, MA; Alexandra E. Fehr, Jean Bosco Bigirimana, Cyprien Shyirambere, Egide Mpanumusingo, Marie O. Benewe, and Christian Rusangwa, Inshuti mu Buzima/Partners in Health; John Butonzi, Butaro District Hospital, Rwanda Ministry of Health, Butaro, Rwanda; Dan M. Kanyike, Uganda Cancer Institute, Kampala, Uganda; Scott Triedman, The Warren Alpert Medical School of Brown University, Providence, RI; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLow- and middle-income countries disproportionately comprise 65% of cancer deaths. Cancer care delivery in resource-limited settings, especially low-income countries in sub-Saharan Africa, is exceedingly complex, requiring multiple modalities of diagnosis and treatment. Given the vast human, technical, and financial resources required, access to radiotherapy remains limited in sub-Saharan Africa. Through 2017, Rwanda has not had in-country radiotherapy services. The aim of this study was to describe the implementation and early outcomes of the radiotherapy referral program at the Butaro Cancer Centre of Excellence and to identify both successful pathways and barriers to care.

methodsButaro District Hospital is located in a rural area of the Northern Province and is home to the Butaro Cancer Centre of Excellence. We performed a retrospective study from routinely collected data of all patients with a diagnosis of cervical, head and neck, or rectal cancer between July 2012 and June 2015.

resultsBetween 2012 and 2015, 580 patients were identified with these diagnoses and were potential candidates for radiation. Two hundred eight (36%) were referred for radiotherapy treatment in Uganda. Of those referred, 160 (77%) had cervical cancer, 31 (15%) had head and neck cancer, and 17 (8%) had rectal cancer. At the time of data collection, 101 radiotherapy patients (49%) were alive and had completed treatment with no evidence of recurrence, 11 (5%) were alive and continuing treatment, and 12 (6%) were alive and had completed treatment with evidence of recurrence.

conclusionThis study demonstrates the feasibility of a rural cancer facility to successfully conduct out-of-country radiotherapy referrals with promising early outcomes. The results of this study also highlight the many challenges and lessons learned in providing comprehensive cancer care in resource-limited settings.

Indexed as

Delivery of Health CareReferral and ConsultationRural PopulationAdultFemaleHumansMaleMiddle AgedNeoplasmsRadiotherapyRetrospective StudiesRwandaTreatment OutcomeUganda

Identifiers

PMID30321096
PMCPMC7010442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.